Public health, innovation, intellectual property and trade

WHO launches book on trade and health

Health and trade have long been interconnected. By publishing Trade and Health: Towards a national strategy, WHO provides useful background information for policy-makers to formulate a coherent national response to trade and health-related issues. With free trade agreements being negotiated continuously, often without sufficient involvement of health experts, the core evidence presented in this book can enable health policy-makers to engage, where health and trade linkages occur, to protect health and thus strike a balance between public health and the further liberalization of global trade.

Ethiopia set to develop pharmaceutical industry to increase access to medicines

The Democratic Republic of Ethiopia, on 14 July 2015, launched an ambitious 10-year national strategy and plan of action to develop local pharmaceutical manufacturing capacity in order to increase access to locally manufactured, quality-assured medicines. The launch occurred on the side-lines of the 3rd Conference on Financing for Development.

Launch of Ethiopia’s National Strategy and Plan of Action for Pharmaceutical Manufacturing

On the occasion of the international conference on financing for development in Addis Ababa, the Prime Minister of Ethiopia with the World Health Organization (WHO) launched a 10-year strategic plan to develop its pharmaceutical manufacturing capacity in order to increase access to local quality-assured medicines. The launch took place on 14 July at 7 p.m. local time and was attended by numerous heads of international agencies.

WHO updates patent information on sofosbuvir and ledipasvir for the treatment of Hepatitic C Virus

World Hepatitis Alliance

New medicines on the market have given new hope to the millions of people who suffer from Hepatitis C Virus (HCV), a chronic disease that often leads to severe liver disease and kills between 350 000-500 000 people annually.
WHO works closely with Member State governments to assess and promote policy options for increasing access to these medicines, which remain unaffordable to many of those who need them and put an enormous financial strain even on the health systems of high-income countries.

Latest activities